These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 1332035
1. Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties. Janáky T, Juhász A, Rékási Z, Serfözö P, Pinski J, Bokser L, Srkalovic G, Milovanovic S, Redding TW, Halmos G. Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10203-7. PubMed ID: 1332035 [Abstract] [Full Text] [Related]
2. Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6. Bajusz S, Janaky T, Csernus VJ, Bokser L, Fekete M, Srkalovic G, Redding TW, Schally AV. Proc Natl Acad Sci U S A; 1989 Aug 01; 86(16):6318-22. PubMed ID: 2548207 [Abstract] [Full Text] [Related]
6. Effect of treatment with LHRH analogs containing cytotoxic radicals on the binding characteristics of receptors for luteinizing-hormone-releasing hormone in MXT mouse mammary carcinoma. Milovanovic SR, Monje E, Szepeshazi K, Radulovic S, Schally A. J Cancer Res Clin Oncol; 1993 Feb 01; 119(5):273-8. PubMed ID: 8382705 [Abstract] [Full Text] [Related]
7. Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on the function of rat pituitary cells: tests in a long term superfusion system. Rékási Z, Szöke B, Nagy A, Groot K, Rékási ES, Schally AV. Endocrinology; 1993 May 01; 132(5):1991-2000. PubMed ID: 8477650 [Abstract] [Full Text] [Related]
8. Synthesis and biological activity of luteinizing hormone-releasing hormone and related peptides. Schafer DJ, Black AD, Bower JD. J Med Chem; 1975 Jun 01; 18(6):613-9. PubMed ID: 1097690 [Abstract] [Full Text] [Related]
9. Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on growth of estrogen-independent MXT mouse mammary carcinoma in vivo. Szepeshazi K, Schally AV, Juhasz A, Nagy A, Janaky T. Anticancer Drugs; 1992 Apr 01; 3(2):109-16. PubMed ID: 1388062 [Abstract] [Full Text] [Related]
10. Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice. Kahán Z, Nagy A, Schally AV, Halmos G, Arencibia JM, Groot K. Breast Cancer Res Treat; 2000 Feb 01; 59(3):255-62. PubMed ID: 10832595 [Abstract] [Full Text] [Related]
11. Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers. Halmos G, Nagy A, Lamharzi N, Schally AV. Cancer Lett; 1999 Mar 01; 136(2):129-36. PubMed ID: 10355741 [Abstract] [Full Text] [Related]
12. Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor. Milovanovic SR, Radulovic S, Schally AV. Breast Cancer Res Treat; 1992 Mar 01; 24(2):147-58. PubMed ID: 8443402 [Abstract] [Full Text] [Related]
13. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Schally AV, Redding TW. Proc Natl Acad Sci U S A; 1987 Oct 01; 84(20):7275-9. PubMed ID: 2890164 [Abstract] [Full Text] [Related]
14. LH-RH analogue carrying a cytotoxic radical is internalized by rat pituitary cells in vitro. Szöke B, Horváth J, Halmos G, Rékási Z, Groot K, Nagy A, Schally AV. Peptides; 1994 Oct 01; 15(2):359-66. PubMed ID: 8008640 [Abstract] [Full Text] [Related]
15. Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer. Pinski J, Reile H, Halmos G, Groot K, Schally AV. Int J Cancer; 1994 Oct 01; 59(1):51-5. PubMed ID: 7927904 [Abstract] [Full Text] [Related]
16. Inhibition of growth of experimental prostate cancer in rats by LH-RH analogs linked to cytotoxic radicals. Pinski J, Schally AV, Yano T, Szepeshazi K, Halmos G, Groot K, Comaru-Schally AM, Radulovic S, Nagy A. Prostate; 1993 Oct 01; 23(2):165-78. PubMed ID: 8378189 [Abstract] [Full Text] [Related]
17. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75. Srkalovic G, Bokser L, Radulovic S, Korkut E, Schally AV. Endocrinology; 1990 Dec 01; 127(6):3052-60. PubMed ID: 2174343 [Abstract] [Full Text] [Related]
18. Inhibitors of the luteinizing hormone-releasing hormone based upon modifications in the 2, 3, and 6 positions. Wan YP, Humphries J, Fisher G, Folkers K, Bowers CY. J Med Chem; 1976 Feb 01; 19(2):199-202. PubMed ID: 765459 [Abstract] [Full Text] [Related]
19. Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH. Kovacs M, Schally AV, Csernus B, Busto R, Rekasi Z, Nagy A. J Neuroendocrinol; 2002 Jan 01; 14(1):5-13. PubMed ID: 11903807 [Abstract] [Full Text] [Related]
20. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Yano T, Pinski J, Radulovic S, Schally AV. Proc Natl Acad Sci U S A; 1994 Mar 01; 91(5):1701-5. PubMed ID: 8127868 [Abstract] [Full Text] [Related] Page: [Next] [New Search]